Osteoarthritis (OA) is a degenerative joint disease characterized by progressive loss of articular cartilage, chondroctye destruction, subchondral bone remodeling, spur formation, and synovial inflammation. OA is believed to be a consequence of mechanical and biochemical events that result in an imbalance between the synthesis and degradation of articular cartilage matrix consisting of proteoglycans (PGs), collagens (type II, IX, XI and others) and water.
which constitutes at least 90% of its molecular mass, consists of many long keratin sulfate, chondroitin sulfate, and glycosaminoglycan (GAG) chains covalently linked to a core protein. 3) Collagen is another component of the articular cartilage, which primarily consists of type II collagen. 4) It plays a role in maintaining integrity of the cartilage matrix and allows proteoglycan to be held in the matrix. 5) The matrix metalloproteinases (MMPs) can degrade all components of the extracellular matrix. MMP-1 is upregulated by the proinflammatory cytokines interleukin-1 (IL-1) and tumor necrosis factor-a (TNF-a) related with the breakdown of cartilage collagen in arthritic diseases. 6 ) MMP-3 is capable of cleaving the aggrecan core protein, as well as type II collagen (in the amino-terminal telopeptide). however, its involvement in the degradation of these proteins in cartilage is unclear.
7) MMP-13 is the most efficient collagenase against type II collagen and it has an important role in cartilage collagen turnover. 8) The activity of MMPs is controlled by a tissue inhibitor of metalloproteinase (TIMP) which inhibits all MMPs at a stoichiometry of 1 : 1 by forming high-affinity complexes. Imbalance between MMPs and TIMPs is well known to be of importance in the progression of OA. 9) Osteoarthritis (OA) is characterized by structural and biochemical changes in chondrocytes and cartilages, and insufficient synthesis of extracellular matrix (ECM) because of chondrocyte phenotype loss (i.e. dedifferentiation) and increased numbers of apoptotic chondrocytes. 10) Chondrocytes are differentiated from mesenchymal cells during embryonic development. Differentiated chondrocytes synthesize sufficient amounts of cartilage-specific ECM, including type II collagen and proteoglycan, to maintain matrix integrity. 11) This homeostasis is recognized to be destroyed by chondrocyte apoptosis in the state of OA.
Chondrocyte apoptosis regulation is modulated by multiple phosphorylation of several different protein kinases. They are major subtypes of mitogen-activated protein (MAP) kinase, such as extracellular signal-regulated kinase ERK-1/2, JNK, p38 kinase and caspase-3. 12, 13) Several studies indicate that JNK and p38 kinase activation processes are associated with apoptosis, whereas ERK activation is coupled with cell survival. So coordinated activation and interactions between ERK and p38 MAP kinase allow cells to respond to various genotoxic and survival factors by affecting a number of downstream targets. 14, 15) It has been also known that the MAP kinase subtypes are activated by proinflammatory cytokines, such as IL-1.
Aralia cordata (A. cordata) has been used in treatment of arthritis and low back pain. It has been reported that A. cor-
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Yong-Hyeon BAEK, a Jeong-Eun HUH, b Jae-Dong LEE, a Do-Young CHOI, a and Dong-Suk PARK* data inhibited COX-2 dependent PGE 2 generation 16) and showed effectiveness regarding analgesia, hypothermia, duration of pentobarbital-induced anesthesia. 17) However, there is no report related to the chondroctye protection and apoptosis inhibition. Therefore, this is the first study to reveal the inhibition effect of A. cordata to cartilage protection and apoptosis inhibition.
In the present study, we intended to reveal the cartilage and chondroctye protection effects of A. cordata by showing the inhibition of chondrocyte apoptosis. For this, we investigated 1) the cartilage and chondrocyte protection effect of A. cordata in interleukin-1a -induced chondrocytes from rabbit articular cartilage, and 2) the inhibition effect of A. cordata on interleukin-1a-induced chondrocyte apoptosis related with JNK, p38, and caspase-3.
MATERIALS AND METHODS

Preparation of Aralia cordata
The root of A. cordata was extracted at room temperature in 70% (v/v) ethanol water for 24 h (productivity of 24.5%). The extract was then filtered and concentrated under low pressure using a vacuum rotary evaporator (Eyela, Japan). The remaining residue was lyophilized in a freeze-dryer, and stored at Ϫ20°C. The powder was dissolved in dimethyl sulfoxide (DMSO) and diluted with Dulbecco's modified Eagle's medium (DMEM) to final concentrations of total extract ranging from 1 to 50 mg/ml.
Cartilage Explants Culture from Rabbit Articular Cartilage Articular cartilages were obtained from the joints of five-week-old rabbits (Samtako Biokorea Co., Korea). In brief, the articular surfaces were surgically exposed under sterile conditions; approximately 200-220 mg of articular surface per joint was removed and steeped in complete medium (DMEM supplemented with heat-inactivated 5% fetal bovine serum [FBS] and 100 unit/ml of penicillinstreptomycin [Gibco BRL, Maryland, U.S.A.]). The samples were then rinsed several times with complete medium and incubated for 12 d at 37°C in a humidified CO 2 /95% air incubator to stabilize them. The complete medium was replaced with basal medium (DMEM supplemented with heat-inactivated 1% FBS, 10 mM HEPES, and 100 unit/ml penicillinstreptomycin).
Treatment of Cartilage Explants with IL-1a a and Aralia cordata Approximately 30 mg of cartilage pieces were placed in 48-well plates and treated with various concentrations of extract of A. cordata. After 1 h of pretreatment, 5 ng/ml IL-1a (R&D Systems, Minneapolis, U.S.A.) was added to the culture media, which were then incubated at 37°C for a further 3 d. The supernatants were harvested and replaced with fresh media containing test reagents. These were incubated for a further 25 d, and 3, 7, 14, and 28 d supernatants were collected and stored at Ϫ20°C until assayed.
Isolation and Culture of Chondrocytes Rabbit articular chondrocytes were cultured from tibial plateaus and femoral condyle in cartilage. 18) Briefly, five-week-old rabbits (Samtako Biokorea Co., Korea) were killed and articular cartilages were removed. Thin slices of cartilage were sequentially digested by 0.2% collagenase type II (Sigma, MI, U.S.A.) and the resulting cell suspension was transferred to 75 cm 2 culture flasks, at 10 5 cells/cm 2 (high density) containing 12 ml DMEM medium (Gibco BRL-Life Technologies), 10% fetal calf serum (FCS), 100 IU/ml penicillin, and 100 mg/ml streptomycin (Roche, Germany) with initial pH 7.2-7.6. Cells were then cultured at 37°C in an atmosphere of 8% CO 2 in air, and the medium was changed once until confluency (day 6 of the culture).
Treatment of Chondrocytes with IL-1a a and Aralia cordata Chondrocytes (1ϫ10 6 /ml) were plated in 6-well plates and serum-starved for 12 h/overnight. The medium was replaced with fresh medium containing recombinant IL-1a (5 ng/ml), and chondrocytes were incubated for 24 h in a tissue culture incubator at 37°C and 5% CO 2 . This concentration of IL-1a was chosen based on pilot experiments performed to determine the lowest concentration of IL-1a that will induce the maximum degradation of proteoglycan and collagen in vitro. To study the dose-dependent effect of A. cordata on IL-1a-induced cartilage destruction, chondrocytes were treated with varying concentrations of A. cordata (1-50 mg/ml). Controls consisted of chondrocytes incubated in the culture medium without IL-1a or A. cordata Effect of Aralia cordata on Cartilage Protection Glycosaminoglycan (GAG) Degradation Assay: Glycosaminoglycan levels in the culture medium were determined by the amount of polyanionic material reacting with 1,9-dimethylmethylene blue, using shark chondroitin sulfate as the standard. Samples were examined spectrophotometrically at 540 nm (Spectramax, Molecular Devices, Sunnyvale, CA, U.S.A.). The percentage recovery was calculated from the peak height of the sample relative to that of the standard.
Collagen Degradation Assay: Type II collagen levels in the culture medium were determined using the Sircol Collagen Assay (Biocolor Ltd., Valley Business Center, Northern Ireland). Samples were reacted with Sirius red dye containing sulfonic acid for 30 min at room temperature. The reaction mixture measured optical density at 540 nm. The percentage of recovery was calculated from the peak height of the sample relative to that of the standard.
Colorimetric Analysis of MMP Activity: The levels of MMP activity in the conditional media were evaluated using an enzyme-linked immunosorbent assay (ELISA) kit (Biomol Research Lab., Inc., PA, U.S.A.) according to the manufacturer's instructions. Briefly, MMP activity was measuredusing a thiopeptolide as a colorimetric substrate (AcPro-Leu-Gly-[2-mercapto-4-methyl-pentanoyl]-Leu-Gly-OC2H5), which is cleaved by stromyelin-1/MMP-3 and collagenase-3/MMP-13. To assess the proteolytic activity, 25 ml of each sample was pipetted into 96 well plates together with each enzyme, buffer and substrate. After 1 h of incubation at 37°C, the amaples were measured at 405 nm. For each sample, MMP-3 and MMP-13 activities were measured as a percentage of the MMPs in that culture well.
Effect of Aralia cordata on Chondroctye Protection Measurement of Gene Expression Type II Collagen, GAG, TIMP-1, MMP-1, MMP-3, and MMP-13: RNA was prepared with Trizol ® reagent (Invitrogen Corporation, CA, U.S.A.). Reverse transcription of 1 mg of total RNA was carried out for 60 min at 42°C and then 15 min at 72°C, using the system for RT-PCR (TaKaRa Biotechnology, Seoul, Korea), PCR using specific primers for each cDNA was carried out in a PCR reaction volume of 10 ml (as supplied by TaKaRa, Korea). Amplification reactions were performed by using type II Collagen, GAG, TIMP-1, MMP-1, MMP-3 and MMP-13 primers (R&D Systems Inc., MN, U.S.A.). An equal volume from each PCR was analyzed by 1.5% agarose gel electrophoresis, and ethidium bromide-stained PCR products were evaluated. Marker gene expression was normalized to GAPDH expression in each sample. Signal intensity was quantified with the Gel Doc EQ (BIO-RAD Laboratories, Milan, Italy).
Measurement of Glycosaminoglycan (GAG) and Collagen Degrading Activities: GAG levels in the culture medium were determined by the amount of polyanionic material reacting with 1,9-dimethylmethylene blue, using shark chondroitin sulfate as the standard. Samples were examined spectrophotometrically at 540 nm (Spectramax, Molecular Devices, Sunnyvale, CA, U.S.A.). The percentage recovery was calculated from the peak height of the sample relative to that of the standard.
Type II collagen levels in the culture medium were determined using the Sircol Collagen Assay (Biocolor Ltd., Valley Business Center, Northern Ireland). Samples were reacted with Sirius red dye containing sulfonic acid for 30 min at room temperature. The reaction mixture measured optical density at 540 nm. The percentage of recovery was calculated from the peak height of the sample relative to that of the standard.
Measurement of MMP Activity: The levels of MMP activity in the conditional media were evaluated using an enzymelinked immunosorbent assay (ELISA) kit (Biomol Research Lab., Inc., PA, U.S.A.) according to the manufacturer's instructions. Briefly, MMP activity was measured using a thiopeptolide as a colorimetric substrate (Ac-Pro-Leu-Gly-[2-mercapto-4-methyl-pentanoyl]-Leu-Gly-OC2H5), which is cleaved by stromyelin-1/MMP-3 and collagenase-3/MMP-13. To assess the proteolytic activity, 25 ml of each sample was pipetted into 96 well plates together with each enzyme, buffer and substrate. After 1 h of incubation at 37°C, the samples were measured at 405 nm. For each sample, MMP-1, MMP-3, and MMP-13 activities were measured as a percentage of the MMPs in that culture well.
Effect of Aralia cordata on Apoptosis Inhibition Western Blotting: Cells were prepared by extracting proteins using a lyses buffer containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 1 mM EDTA, supplemented with protease inhibitors (10 mg/ml leupeptin, 10 mg/ml aprotinin, 10 mg/ml pepstatin A, and 1 mM of 4-(2-aminoethyl) benzenesulfonyl fluoride) and phosphatase inhibitors (1 mM NaF and 1 mM Na 3 VO 4 ). After centrifugation, the pellet was resuspended in the loading buffer containing 50 mM Tris-HCl (pH 6.8), 4% glycerol, 2 mM EDTA, 3% SDS, and 0.01% bromphenol blue. The proteins were sizefractionated by SDS-polyacrylamide gel electrophoresis and transferred to Hybond-C nitrocellulose membranes for 2 h at 300 mA using a transfer system. Membranes were blocked with 5% nonfat dry milk in TBS-T (0.05% Tween-20, 138 mM NaCl, and 25 mM Tris base). Protein expression was determined using antibodies purchased from the following sources: rabbit anti-phospho ERK-1/2, JNK and p38. The blots were incubated with a horseradish peroxidase-conjugated goat anti-rabbit IgG and enhanced with chemiluminescene (ECL) detection system (Amersham Life Science, Alington Heights, IL U.S.A.).
Measurement of Apoptotic Cells by Flow Cytometry: For flow cytometric analysis of sub G1 cell counting with fragmented DNA, 5ϫ10 5 cells/well onto 6-well plates were collected at different concentrations for 24 h. The cells were harvested and incubated with 1 mlof 75% cold ethanol for 2 h at Ϫ20°C and then washed with PBS. Cell pellets were incubated with 10 mg/ml RNase before adding 50 mg/ml propidium iodide (PI). Samples were analyzed on a FACSort flow cytometer using the cell quest analysis program (Becton Dickinson, San Jose, CA, U.S.A.), which is also used to determine the percentage of sub GI cells. PI was excited at 488 nm, and fluorescence was analyzed at 620 mm.
Annexin V Staining: To quantify the percentage of cells undergoing apoptosis, we also used Annexin V-FITC kit (Caltag, U.S.A.) as manufacture described. Briefly, chondrocyte cells were incubated for 24 h with IL-1 a, A. cordata, kinase inhibitors (PD98059, SP600125, SB203580). Then the cells were washed twice with cold PBS and resuspended in blinding buffer at a concentration of 5ϫ10 6 cells/ml. After incubation, 100 ml of the solution was transferred to a 5 ml culture tube, and 5 ml of Annexin V-FITC and 10 ml of PI were added. The tube was gently vortexed and incubated for 15 min at room temperature in the dark. At the end of incubation, 400 ml of binding buffer was added, and the cells were analyzed immediately by flow cytemetry.
Measurement of Caspase-3 Activity: Caspase-3 activation in IL-1a-treated chondrocytes was determined by measuring the absorbance of a cleaved synthetic substrate of caspase-3, Ac-Asp-Glu-Val-Asp-chromophore p-nitroaniline. Briefly, chondrocytes were lysed on ice for 10 min in cell lysis buffer provided in the Clontech A ApoAlert TM CPP32 colorimetric assay kit. Lysates were reacted with 50 mM Ac-Asp-Glu-ValAsp-chromophore p-nitroaniline in reaction buffer (0.1 M HEPES, 20% glycerol, 10 mM dithiothreitol, and protease inhibitors (pH 7.4)). Mixtures were maintained at 37°C for 1 h in a water bath and subsequently analyzed in an enzymelinked immunosorbent assay reader. Enzyme activity was calculated from a standard curve prepared using p-nitroaniline. The relative levels of p-nitroaniline were normalized against the protein concentration of each extract.
Statistical Analysis: All data were represented as meansϮ S.E.M. The significance of statistical differences among groups were determined using one way analysis of variance (ANOVA) followed by Dunnett's post-hoc test. And between two groups, the statistically significant differences were determined by Student's t-test or paired t-test. Differences were considered significant when p value was less than 0.05.
RESULTS
Effect of Aralia cordata on Glycosaminoglycan (GAG) and Collagen Degradation in Cartilage Explants Cultures
To study whether A. cordata affects GAG and collagen degradation in rabbit cartilage explants, rabbit cartilage explants were cultured in the presence of 5 ng/ml IL-1a for 28 d. A. cordata reduced the IL-1a-mediated GAG release into the culture medium until 14 d. No release of collagen into the culture medium was observed from explants treated with 5 ng/ml IL-1a up to 7 d. After 14 d, A. cordata markedly reduced collagen degradation relative to that in the IL-1a-treated cultures, and significantly reduced up to 28 d (data are not shown). A. cordata dose-dependently reduced IL-1a-me-diated GAG and collagen release into the culture medium. A. cordata significantly reduced GAG and collagen release starting from a low concentration of 0.02 mg/ml, and almost totally inhibited it at a concentration of 0.2 mg/ml for 14 d. (Fig. 1) .
Effect of Aralia cordata on MMP Activity in Cartilage Explants Cultures
We examined whether A. cordata inhibited IL-1a-mediated TIMP-1, MMP-1, MMP-3 and MMP-13 activities in the culture medium. We tested the levels of TIMP-1, MMP-1, MMP-3 and MMP-13 activitites in the IL-1a-treated culture media after 14 d with or without A. cordata treatment. In the A. cordata-treated culture media, MMP-1, MMP-3 and MMP-13 levels were significantly decreased in a dose dependent manner compared with the group of IL-1a-treated culture media without A. cordata treatment. And TIMP-1 level was significantly increased dose-dependently compared with the group of IL-1a-treated culture media without A. cordata treatment (Fig. 2) .
De-differentiation Induced by IL-1a a and Serial Passage of Chondrocytes We examined the de-differentiation followed by IL-1a & serial passage in primary culture of articular cartilage. In this experiment, we knew that 5 ng/ml IL1a induce the definite de-differentiation of chondrocytes in both passage #1 and passage #5, and that the degree of dedifferentiation was more severe in passage #5 (data are not shown). On the basis of this result, we used the sample induced by 5 ng/ml IL-1a in passage #5.
Effects of Aralia cordata on the Gene Expression and Activity of GAG, Collagen, TIMP, and MMPs The effects of A. cordata on the gene expressions of GAG, collagen, TIMP, and MMPs were investigated with increasing dosages. The expressions of collagen and proteoglycan were increased by A. cordata treatment in a dose-dependent manner (Fig. 3) . A. cordata increased the gene expression of TIMP-1 and reduced the expressions of MMP-1, MMP-3, and MMP-13 in a dose-dependent manner (Fig. 4) .
Effects of Aralia cordata and MAP Kinase Inhibitors on Chondrocyte Apoptosis Chondrocytes were exposed to A. cordata and MAP kinase inhibitors, such as PD98059, SP600125 and SB203580, in order to identify the roles of ERK-1/2, JNK, and p38 signaling pathways during IL-1a-induced apoptosis. When chondrocytes were treated with 5 ng/ml IL-1a, ERK-1/2 activity was decreased, as determined by phosphorylation status of the protein. However, A. cordata increased the ERK-1/2 activity compared to the IL1a-treated group. On the contary, 5 ng/ml IL-1a treatment Cartilage was cultured in quadruplicate in 400 ml of medium only, medium with 5 ng/ml IL-1a, and medium with 5 ng/ml IL-1a plus different concentrations of A. cordata for 14 d. The media were removed on 3 d and replaced as described above for a further 11 d. The levels of GAG and collagen release into the media on 14 d were measured and the results are expressed as a percentage of the total compound release. Df, a non-selective COX-2 inhibitor diclofenac. Data were obtained from three independent experiments and each datum was represented as meanϮS.E.M. ### pϽ0.001 compared with medium only group (DSF). * * * pϽ0.001 compared with IL-1a group.
Fig. 2. Effect of Aralia cordata on MMP Activity in Rabbit Cartilage Explants Cultures
Cartilages were cultured in medium only, medium with 5 ng/ml IL-1a, medium with 5 ng/ml IL-1a plus different concentrations of A. cordata, and medium with 104 mM BB94, an MMP inhibitor, for 14 d. Cumulative TIMP-1, MMP-1, MMP-3 and MMP-13 activities were analyzed with a colorimetric substrate assay. Df, a non-selective COX-2 inhibitor diclofenac. Data were obtained from three independent experiments and each datum was represented as meanϮS.E.M. ### pϽ0.001 compared with medium only group (DSF). * pϽ0.05, *** pϽ0.001 compared with IL-1a group.
increased phospho JNK and p38 activity. In this case, A. cordata. decreased the phospho JNK and p38 activtiy compared to the IL-1a-treated group (Fig. 5) .
Effects of Aralia cordata on Chondrocyte Apoptosis in Flow Cytometric Analysis IL-1a increased apoptotic sub-G1 phase cells in a dose-dependent manner. However, there were no significant differences in a dose over 5 ng/ml (data are not shown). A. cordata in the presence of 5 ng/ml IL-1a markedly decreased apoptotic sub-G1 phase cells by propidium iodide (PI) staining using flow cytometric analysis. SP600125, and SB203580, JNK and p38 MAP kinase inhibitor, also decreased apoptotic sub-G1 phase cells. However, PD98059, ERK MAP kinase inhibitor, markedly increased apoptotic sub-G1 phase cells (Fig. 6A) . Inhibitory effect of A. cordata on apoptosis also confirmed using Annexin V staining to detect externalization of phosphatidylserine (PS) on the cell membrane. A. cordata in the presence of 5 ng/ml IL-1a markedly decreased apoptotic cells. Also, SP600125 and SB203580 decreased apoptotic cells, but PD98059 increased apoptotic cells (Fig. 6B) .
Effects of Aralia cordata on Caspase-3 Activity in Chondrocytes IL-1a significantly increased the caspase-3 activity in chondrocytes. A. cordata in the presence of 5 ng/ml IL-1a dose-dependently decreased the caspase-3 activity. SP600125 and SB203580, JNK and p38 MAP kinase inhibitor, also dose-dependently decreased the caspase-3 activity. In contrast, PD98059, ERK MAP kinase inhibitor, significantly increased the caspase-3 activity in a dose-dependent manner (Fig. 7) .
DISCUSSION
Aralia cordata is an oriental medicinal herb which has been used for the treatment of OA. However, the current problem is "How can we prove the cartilage protective effect of A. cordata in OA?" Moreover, there have been no studies related to the chondroprotective and anti-apoptotic effect of A. cordata. Therefore, we investigated the cartilage protective and anti-apoptotic effects of A. cordata in in vitro study by using cartilage explants cultures and chondroctyes from rabbit articular cartilage.
In general, the destruction of cartilage in OA is initially caused by a decrease in its proteoglycan content, followed by the degradation of collagen fibers. Some studies have suggested that examination of both proteoglycan and collagen matrix should be included to reveal the cartilage destruction. 18, 19) In a preliminary study, we confirmed that glycosaminoglycan (GAG), a component of proteoglycan, and collagen were dose-dependently degraded by IL-1a. Also, maximal degradation was induced at the concentration of 5 ng/ml IL-1a, 14 d after the administration to rabbit cartilage explants (data are not shown). Also, we confirmed that A. cordata had no toxicity in concentration range from 1 to 100 mg/ml by MTT assay (data not shown). On basis of such result, we investigated the inhibitory effects of A. cordata on IL-1a-induced GAG and collagen release in rabbit cartilage explants cultures. In this study, A. cordata dose-dependently reduced IL-1a-induced GAG and collagen release into the culture medium on 14 d (Figs. 1, 2) . These results suggest that A. cordata can be effective for reduction of GAG and collagen degradation in rabbit cartilage. Diclofenac, a non- selective COX-2 inhibitor as a control, showed inhibitory effect and this result is consistent with the report in which diclofenac showed inhibitiory effect on cartilage metabolism. 20) A. cordata also dose-dependently increased TIMP-1 activity, and inhibited MMP-1, MMP-3 and MMP-13 activities in articular cartilage explants (Fig. 2) . These results suggest that A. cordata showed the inhibitory effect on cartilage loss. Proteoglycan is particularly vulnerable to proteinase attack and is, therefore, a sensitive indicator of proteolytic activity. Studies by Lin et al. suggested that MMPs, as proteinases, were responsible for the release of proteoglycan and collagen. 21, 22) Furthermore, Kozaci et al. suggested that MMPs were related to the cartilage destruction stimulated by IL-1a, type II collagen breakdown in bovine nasal cartilage explants. 23, 24) In preliminary study, on 5 d of chondrocyte passage #0, round-shape normal chondrocytes were observed. IL-1a and serial passages induced de-differentiation of chondrocytes in primary culture of rabbit articular chondrocytes. On basis of such result, we used the choncrocytes of passage #5 with IL1a treatment to reveal the change of gene expression of GAG, collagen, TIMP-1, and MMPs by IL-1a treatment. A. cordata treatment markedly increased the expressions of GAG, collagen, and TIMP-1 which were reduced by IL-1a treatment. Also, A. cordata inhibited the expressions and activities of MMP-1, -3, and -13 which were increased by IL1a (Figs. 3, 4) . These findings suggest that A. cordata showed the chodroprotective effect through the regulation of GAG, collagen, TIMP-1, and MMPs activity.
On the basis of the chondroprotective effect of A. cordata, we intended to investigate the inhibitory effect of A. cordata on chondrocyte apoptosis. In general, OA is characterized by structural and biochemical changes in chondrocytes and cartilages, including degradation of the cartilage matrix, because of increased numbers of apoptotic chondrocytes. Apoptosis is induced by the activation of caspases through the regulation of MAPK signaling pathway, such as ERK-1/2, JNK, and p38. Thus, we investigated whether A. cordata inhibits the apoptosis by the suppression of caspase-3 activity.
A. cordata increased the phosphorylation of ERK-1/2 and decreased the phosphorylation of JNK and p38 kinase (Fig.  5) . ERK-1/2 activates anti-apoptotic signal, whereas JNK and p38 kinase acts as an induction signal for apoptosis. [25] [26] [27] This fact implies that A. cordata showed the anti-apoptotic effect by suppression of JNK and p38 expression. Also, in flow cytometric analysis, we confirmed that A. cordata markedly decreased IL-1a induced apoptotic cells (Fig. 6) . IL-1a treatment induced apoptosis via caspase-3 activation, and A. cordata inhibited the caspase-3 activity in a dose-dependent manner (Fig. 7) . PD98059, ERK-1/2 inhibitor, increased the activation of apoptotic sub-G1 cells and caspase-3 activation. On the contrary, SP600125, JNK inhibitor, and SB203580, p38 inhibitor, decreased the activation of apoptotic sub-G1 cells and caspase-3 activity. These data are consistent with the study in which the inhibition of ERK with PD98059 activated the pro-apoptotic signal, and the inhibition of JNK and p38 phosphorylation induced the anti-apoptotic signal. 25, 26, 28) On the basis of these results, we knew that A. cordata showed the anti-apoptotic effect through JNK and p38 MAPK pathway.
In conclusion, A. cordata showed the cartilage and chondroprotective effect through the inhibition of GAG and collagen degradation, increase of TIMP-1 activity, and decrease of MMPs (MMP-1, -3, -13) activities. And also, A. cordata inhibited the apoptosis through the downregulation of JNK/p38 MAP kinase signal and the inhibition of caspase-3 activity in in vitro study using cultured chondroctyes from rabbit articular cartilage.
